• Dexter Studios corrected its reverse stock split schedule, moving the effective date to Nov. 19, 2026, from Nov. 5, 2026.
• The extraordinary shareholder meeting was postponed to Nov. 4, 2026, from Oct. 21, 2026, prompting the schedule changes.
• Trading suspension shifts to Nov. 17–Dec. 4, 2026, from Nov. 3–23, 2026.
• New shares are scheduled to list on Dec. 7, 2026, instead of Nov. 24, 2026.
• The 1-for-2 reverse split will reduce outstanding common shares to 12,705,868 from 25,411,736.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dexter Studios Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261020900423), on October 20, 2026, and is solely responsible for the information contained therein.